News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
AstraZeneca PLC Sees More Deals to Fill Out Pipeline
May 5, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Anglo-Swedish drugmaker AstraZeneca is aggressively meeting potential acquisition partners as it prepares for generic competition from some of its best-selling drugs.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
AstraZeneca
MORE ON THIS TOPIC
Deals
CSL strikes up to $1.6B deal with Alentis for autoimmune drug with broad potential
October 5, 2026
·
2 min read
·
Tristan Manalac
Insights
Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand
October 5, 2026
·
6 min read
·
Jennifer C. Smith-Parker
Layoff Tracker
Foghorn cuts 40% of workforce
October 2, 2026
·
98 min read
·
BioSpace Editorial Staff
Duchenne muscular dystrophy
Sarepta could be ‘potential turnaround story’ with catalysts lined up into 2027
October 2, 2026
·
3 min read
·
Heather McKenzie
